Financing ·
Jupiter Neurosciences, Inc. issued and sold 11,470,000 shares of common stock to Yorkville II PN, Ltd. under a Standby…
JUNSJupiter Neurosciences, Inc.
Jupiter Neurosciences, Inc. issued and sold 11,470,000 shares of common stock to Yorkville II PN, Ltd. under a Standby Equity Purchase Agreement between May 14, 2026, and July 24, 2026. The transaction generated approximately $3.6 million in aggregate gross proceeds, with the per-share price set at 97% of the lowest daily volume-weighted average price during the relevant pricing periods. Following these issuances, the company reported 56,520,143 shares of common stock issued and outstanding as of July 28, 2026. Jupiter Neurosciences, Inc. operates in the biotechnology industry, focusing on the development of therapies for neurological disorders.